Answers are grounded in this paper and cite their sources.
Preclinical study reveals novel tricyclic spiroindoles that inhibit P-glycoprotein in drug-resistant tumors, highlighting strategies to overcome multidrug resistance.
P-gp inhibition. In conclusion, this study provides a novel skeleton that inspires the design of new P-gp inhibitors, laying the foundation for the treatment of drug-resistant tumors.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: